Robert Califf, who previously served as FDA commissioner, has indicated that political pressures have significantly altered the operational landscape of the agency.
He notes that the current administration perceives FDA decisions through a political lens, diverging from its traditional scientific and regulatory focus.
This shift raises implications for the FDA's capacity to function effectively, potentially impacting public health outcomes and regulatory integrity.